General Information
Drug ID
DR00243
Drug Name
Mycophenolate mofetil
Synonyms
2-Morpholinoethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate; 2-Morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate; 2-morpholin-4-ylethyl (4E)-6-[4-hydroxy-7-methyl-6-(methyloxy)-3-oxo-1,3-dihydro-2-benzofuran-5-yl]-4-methylhex-4-enoate; 2-morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate;4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (4E); CellCept; CellCept, RS 61443, TM-MMF, Mycophenolate mofetil; Cellcept (TN); ME-MPA; MMF; MMF CellCept(TM); Munoloc; Mycophenolate mofetil (JAN/USAN); Mycophenolic acid morpholinoethyl ester; Mycophenylate mofetil; R-99; RS 61443; RS-61443; RS-61443-190; TM-MMF
Drug Type
Small molecular drug
Indication Pemphigus vulgaris [ICD11: EB40.0] Approved [1]
Therapeutic Class
Immunosuppressive Agents
Structure
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=5281078"></iframe>
3D MOL 2D MOL
Formula
C23H31NO7
Canonical SMILES
CC1=C(C(=C(C2=C1COC2=O)O)CC=C(C)CCC(=O)OCCN3CCOCC3)OC
InChI
InChI=1S/C23H31NO7/c1-15(5-7-19(25)30-13-10-24-8-11-29-12-9-24)4-6-17-21(26)20-18(14-31-23(20)27)16(2)22(17)28-3/h4,26H,5-14H2,1-3H3/b15-4+
InChIKey
RTGDFNSFWBGLEC-SYZQJQIISA-N
CAS Number
CAS 128794-94-5
Pharmaceutical Properties Molecular Weight 433.501 Topological Polar Surface Area 94.5
Heavy Atom Count 31 Rotatable Bond Count 10
Hydrogen Bond Donor Count 1 Hydrogen Bond Acceptor Count 8
PubChem CID
5281078
PubChem SID
10110 , 103524891 , 103831140 , 104253178 , 113854519 , 117622077 , 118053002 , 12014254 , 124757298 , 125164102 , 125275456 , 126592936 , 126621236 , 126622394 , 126651543 , 126669998 , 126682700 , 131295332 , 131297141 , 132003527 , 134338068 , 134339833 , 135016986 , 135039794 , 136949095 , 137004579 , 142385187 , 144075766 , 14758955 , 29215410 , 39289999 , 46505626 , 48416299 , 49830660 , 49976609 , 50064190 , 537396 , 56310881 , 56312885 , 57358003 , 62129612 , 623972 , 77319688 , 7847817 , 80954261 , 8616507 , 92308999 , 92718908 , 93619754 , 96099842
ChEBI ID
ChEBI:93612
TTD Drug ID
D04FBR
DT(s) Transporting This Drug BCRP Transporter Info Breast cancer resistance protein Substrate [2]
MRP2 Transporter Info Multidrug resistance-associated protein 2 Substrate [3]
OATP1B1 Transporter Info Organic anion transporting polypeptide 1B1 Substrate [3]
OATP1B3 Transporter Info Organic anion transporting polypeptide 1B3 Substrate [3]
P-GP Transporter Info P-glycoprotein 1 Substrate [2]
References
1 Mycophenolic acid was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Influence of drug transporters and UGT polymorphisms on pharmacokinetics of phenolic glucuronide metabolite of mycophenolic acid in Japanese renal transplant recipients. Ther Drug Monit. 2008 Oct;30(5):559-64.
3 Influence of SLCO1B1, 1B3, 2B1 and ABCC2 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients. Eur J Clin Pharmacol. 2007 Dec;63(12):1161-9.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.